ARTICLE | Company News
ID Biomedical other research news
June 11, 2001 7:00 AM UTC
IDBE's Intellivax International subsidiary will receive C$5.9 million (US$3.8 million) in funding from Technology Partnership Canada over the next three years to develop its Proteasomes technology to ...